DCM
IDXX icon

Davis Capital Management’s Idexx Laboratories IDXX Stock Holding History

Davis Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$526 Buy
+1
New +$561 ﹤0.01% 606
2026
Q1 		– Sell
-1
Closed -$677 – 618
2025
Q4 		$677 Hold
1
– – ﹤0.01% 368
2025
Q3 		$639 Buy
+1
New +$607 ﹤0.01% 375

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Davis Capital Management's IDXX Position: Q2 2026 in Review

Davis Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 1 share worth $526. The stake represents ﹤0.01% of the portfolio and ranks #606 among its holdings. This is a return to the name: Davis Capital Management previously reported a position in IDXX as recently as Q4 2025.

Davis Capital Management first reported a position in IDXX in Q3 2025 and has held it in 3 quarters since. The position peaked at $677 in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Davis Capital Management held 1 share of Idexx Laboratories worth $526 as of Q2 2026.
  • Idexx Laboratories was a new Davis Capital Management position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #606 holding.
  • Davis Capital Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 3 quarters since.
  • Davis Capital Management's Idexx Laboratories position peaked at $677 in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.